Management of Renal Disease

  • Author: Mohamed G. Atta, MD, MPH (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/14/17 (What's New)

Summary

  • Ability of cystatin C to act as a true marker of kidney function limited by the effects of processes other than kidney function, such as inflammation and apoptosis
  • Its use among persons with HIV infection, particularly those with high HIV-1 RNA levels, is questionable and is not recommended[Bhasin 2013]
    • Combined eGFR creatinine–cystatin C equation is most accurate in HIV-positive patients

Action required

Keywords: Renal Complications

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.